About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 639748, 8 pages
http://dx.doi.org/10.1155/2012/639748
Clinical Study

Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus

Department of Surgery, Hospital de Clínicas de Porto Alegre, School of Medicine, Federal University of Rio Grande do Sul, 90035-903 Porto Alegre, RS, Brazil

Received 24 April 2012; Accepted 26 May 2012

Academic Editor: Jin-Lian Chen

Copyright © 2012 Bernardo Silveira Volkweis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Peters, J. A. Hagen, and S. R. DeMeester, “Barrett's esophagus,” Journal of Gastrointestinal Surgery, vol. 8, no. 1, pp. 1–17, 2004.
  2. G. J. S. Jenkins, S. H. Doak, J. M. Parry, F. R. D'Souza, A. P. Griffiths, and J. N. Baxter, “Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma,” British Journal of Surgery, vol. 89, no. 7, pp. 824–837, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Cameron and H. A. Carpenter, “Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study,” American Journal of Gastroenterology, vol. 92, no. 4, pp. 586–591, 1997. View at Scopus
  4. J. Lagergren, R. Bergström, A. Lindgren, and O. Nyrén, “Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma,” New England Journal of Medicine, vol. 340, no. 11, pp. 825–831, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Cameron, B. J. Ott, and W. S. Payne, “The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus,” New England Journal of Medicine, vol. 313, no. 14, pp. 857–859, 1985. View at Scopus
  6. S. R. DeMeester and T. R. DeMeester, “Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy,” Annals of Surgery, vol. 231, no. 3, pp. 303–321, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Spechler, “The natural history of dysplasia and cancer in esophagitis and Barrett esophagus,” Journal of Clinical Gastroenterology, vol. 36, no. 5, supplement, pp. S2–S5, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. S. Devesa, W. J. Blot, and J. F. Fraumeni Jr., “Changing patterns in the incidence of esophageal and gastric carcinoma in the United States,” Cancer, vol. 83, no. 10, pp. 2049–2053, 1998.
  9. H. Pohl, B. Sirovich, and H. G. Welch, “Esophageal adenocarcinoma incidence: are we reaching the peak?” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 6, pp. 1468–1470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. G. de Barros, R. M. Vidal, L. P. Luz, et al., “Prevalence of adenocarcinoma of the esophagus and esophagogastric junction in a 10 year period at a cancer referral center in southern Brazil,” Arquivos de Gastroenterologia, vol. 36, no. 1, pp. 32–36, 1999.
  11. S. Szachnowicz, I. Cecconello, K. Iriya, A. G. Marson, F. R. Takeda, and J. J. Gama-Rodrigues, “Origin of adenocarcinoma in Barrett's esophagus: p53 and Ki67 expression and histopathologic background,” Clinics, vol. 60, no. 2, pp. 103–112, 2005. View at Scopus
  12. T. W. Rice, V. W. Rusch, H. Ishwaran, and E. H. Blackstone, “Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals,” Cancer, vol. 116, no. 16, pp. 3763–3773, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. H. Hölscher, E. Bollschweiler, P. M. Schneider, and J. R. Siewert, “Early adenocarcinoma in Barrett's oesophagus,” British Journal of Surgery, vol. 84, no. 10, pp. 1470–1473, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Nobukawa, S. C. Abraham, J. Gill, R. F. Heitmiller, and T. T. Wu, “Clinicopathologic and molecular analysis of high-grade dysplasia and early adenocarcinoma in short- versus long-segment Barrett esophagus,” Human Pathology, vol. 32, no. 4, pp. 447–454, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. B. J. Reid, R. C. Haggitt, C. E. Rubin et al., “Observer variation in the diagnosis of dysplasia in Barrett's esophagus,” Human Pathology, vol. 19, no. 2, pp. 166–178, 1988. View at Scopus
  16. D. S. Levine, R. C. Haggitt, P. L. Blount, P. S. Rabinovitch, V. W. Rusch, and B. J. Reid, “An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus,” Gastroenterology, vol. 105, no. 1, pp. 40–50, 1993. View at Scopus
  17. C. D. Lao, M. Simmons, S. Syngal et al., “Dysplasia in Barrett esophagus: implications for chemoprevention,” Cancer, vol. 100, no. 8, pp. 1622–1627, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. R. R. Gurski, J. H. Peters, J. A. Hagen et al., “Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features,” Journal of the American College of Surgeons, vol. 196, no. 5, pp. 706–713, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. J. F. Fléjou, “Barrett's oesophagus: from metaplasia to dysplasia and cancer,” Gut, vol. 54, no. 1, pp. i6–i12, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Montgomery, J. R. Goldblum, J. K. Greenson et al., “Dysplasia as a predictive marker for invasive carcinoma in barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study,” Human Pathology, vol. 32, no. 4, pp. 379–388, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Edwards, D. R. Gable, A. B. Lentsch, and J. D. Richardson, “The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia,” Annals of Surgery, vol. 223, no. 5, pp. 585–591, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Sikkema, C. W. N. Looman, E. W. Steyerberg et al., “Predictors for neoplastic progression in patients with Barrett's esophagus: a prospective cohort study,” American Journal of Gastroenterology, vol. 106, no. 7, pp. 1231–1238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. B. J. Reid, “Barrett's esophagus and esophageal adenocarcinoma,” Gastroenterology Clinics of North America, vol. 20, no. 4, pp. 817–834, 1991. View at Scopus
  24. B. J. Reid, P. L. Blount, C. E. Rubin, D. S. Levine, R. C. Haggitt, and P. S. Rabinovitch, “Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort,” Gastroenterology, vol. 102, no. 4, pp. 1212–1219, 1992. View at Scopus
  25. D. B. Skinner, B. C. Walther, and R. H. Riddell, “Barrett's esophagus. Comparison of benign and malignant cases,” Annals of Surgery, vol. 198, no. 4, pp. 554–566, 1983. View at Scopus
  26. P. Chandrasoma, “Pathophysiology of Barrett's esophagus,” Seminars in Thoracic and Cardiovascular Surgery, vol. 9, no. 3, pp. 270–278, 1997. View at Scopus
  27. T. R. DeMeester, “Clinical biology of the Barrett's metaplasia, dysplasia to carcinoma sequence,” Surgical Oncology, vol. 10, no. 3, pp. 91–102, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Öberg, J. H. Peters, T. R. DeMeester et al., “Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease,” Annals of Surgery, vol. 226, no. 4, pp. 522–532, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. C. P. Morales, R. F. Souza, and S. J. Spechler, “Hallmarks of cancer progression in Barrett's oesophagus,” The Lancet, vol. 360, no. 9345, pp. 1587–1589, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Jankowski, N. A. Wright, S. J. Meltzer et al., “Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus,” American Journal of Pathology, vol. 154, no. 4, pp. 965–973, 1999. View at Scopus
  31. B. P. L. Wijnhoven, H. W. Tilanus, and W. N. M. Dinjens, “Molecular biology of Barrett's adenocarcinoma,” Annals of Surgery, vol. 233, no. 3, pp. 322–337, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. D. S. A. Sanders, P. Taniere, R. F. Harrison, and J. A. Z. Jankowski, “Clinical and molecular pathology of the metaplasia-dysplasia-carcinoma sequence in Barrett's oesophagus,” Current Diagnostic Pathology, vol. 9, no. 4, pp. 235–241, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Endl and J. Gerdes, “The Ki-67 protein: fascinating forms and an unknown function,” Experimental Cell Research, vol. 257, no. 2, pp. 231–237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. D. McCormick, H. Chong, C. Hobbs, C. Datta, and P. A. Hall, “Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1,” Histopathology, vol. 22, no. 4, pp. 355–360, 1993. View at Scopus
  35. M. Kerkhof, E. W. Steyerberg, J. G. Kusters et al., “Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus,” Cancer Biomarkers, vol. 4, no. 1, pp. 1–10, 2008. View at Scopus
  36. M. Feith, H. J. Stein, J. Mueller, and J. R. Siewert, “Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53,” Diseases of the Esophagus, vol. 17, no. 4, pp. 322–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Rioux-Leclercq, B. Turlin, F. Sutherland et al., “Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus,” Oncology Reports, vol. 6, no. 4, pp. 877–882, 1999. View at Scopus
  38. G. Y. Lauwers, O. Kandemir, P. S. Kubilis, and G. V. Scott, “Cellular kinetics in Barrett's epithelium carcinogenic sequence: roles of apoptosis, bcl-2 protein, and cellular proliferation,” Modern Pathology, vol. 10, no. 12, pp. 1201–1208, 1997. View at Scopus
  39. M. Xu, Y. L. Jin, J. Fu et al., “The abnormal expression of retinoic acid receptor-β, p53 and Ki67 protein in normal, premalignant and malignant esophageal tissues,” World Journal of Gastroenterology, vol. 8, no. 2, pp. 200–202, 2002. View at Scopus
  40. H. J. Stein, M. Feith, and J. R. Siewert, “Cancer of the esophagogastric junction,” Surgical Oncology, vol. 9, no. 1, pp. 35–41, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Montgomery, M. P. Bronner, J. R. Goldblum et al., “Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation,” Human Pathology, vol. 32, no. 4, pp. 368–378, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Faller, F. Borchard, C. Ell et al., “Histopathological diagnosis of Barrett's mucosa and associated neoplasias: results of a consensus conference of the Working Group for Gastroenterological Pathology of the German Society for Pathology on 22 September 2001 in Erlangen,” Virchows Archiv, vol. 443, no. 5, pp. 597–601, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. G. J. A. Offerhaus, P. Correa, S. Van Eeden et al., “Report of an Amsterdam Working Group on Barrett Esophagus,” Virchows Archiv, vol. 443, no. 5, pp. 602–608, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. L.-Q. Chen, C.-Y. Hu, L. Gaboury, M. Pera, P. Ferraro, and A. C. Duranceau, “Proliferative activity in Barrett's esophagus before and after antireflux surgery,” Annals of Surgery, vol. 234, no. 2, pp. 172–180, 2001. View at Scopus
  45. J. Gerdes, H. Pickartz, J. Brotherton, J. Hammerstein, H. Weitzel, and H. Stein, “Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies,” American Journal of Pathology, vol. 129, no. 3, pp. 486–492, 1987. View at Scopus
  46. A. H. Mulder, J. C. S. P. Van Hootegem, R. Sylvester et al., “Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67),” Journal of Pathology, vol. 166, no. 1, pp. 37–43, 1992. View at Scopus
  47. N. E. Tzanakis, G. Peros, P. Karakitsos et al., “Prognostic significance of p53 and Ki67 proteins expression in greek gastric cancer patients,” Acta Chirurgica Belgica, vol. 109, no. 5, pp. 606–611, 2009. View at Scopus
  48. R. Porschen, A. Kriegel, C. Langen et al., “Assessment of proliferative activity in carcinomas of the human alimentary tract by Ki-67 immunostaining,” International Journal of Cancer, vol. 47, no. 5, pp. 686–691, 1991. View at Scopus
  49. S. Y. Iftikhar, R. J. C. Steele, S. Watson, P. D. James, K. Dilks, and J. D. Hardcastle, “Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus,” Gut, vol. 33, no. 6, pp. 733–737, 1992. View at Scopus
  50. B. J. Reid, C. A. Sanchez, P. L. Blount, and D. S. Levine, “Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression,” Gastroenterology, vol. 105, no. 1, pp. 119–129, 1993. View at Scopus
  51. B. J. Reid, D. S. Levine, G. Longton, P. L. Blount, and P. S. Rabinovitch, “Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets,” American Journal of Gastroenterology, vol. 95, no. 7, pp. 1669–1676, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. M. M. Reid, “Flow cytometry and Kleihauer tests,” Journal of Clinical Pathology, vol. 49, no. 4, p. 354, 1996. View at Scopus
  53. R. C. Haggitt, B. J. Reid, P. S. Rabinovitch, and C. E. Rubin, “Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk,” American Journal of Pathology, vol. 131, no. 1, pp. 53–61, 1988. View at Scopus
  54. T. Scholzen and J. Gerdes, “The Ki-67 protein: from the known and the unknown,” Journal of Cellular Physiology, vol. 182, no. 3, pp. 311–322, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. M. K. Hong, W. B. Laskin, B. E. Herman et al., “Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus,” Cancer, vol. 75, no. 2, pp. 423–429, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Polkowski, J. J. B. Van Lanschot, F. J. W. Ten Kate et al., “The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence,” Surgical Oncology, vol. 4, no. 3, pp. 163–171, 1995. View at Scopus
  57. P. Bhargava, G. M. Eisen, D. A. Holterman et al., “Endoscopic mapping and surrogate markers for better surveillance in Barrett esophagus: a study of 700 biopsy specimens,” American Journal of Clinical Pathology, vol. 114, no. 4, pp. 552–563, 2000. View at Publisher · View at Google Scholar · View at Scopus